Ozempic Price Draws New Call for Biden to Seize Drug Patents (2)

The Biden administration is facing pressure to lower the price of the blockbuster weight-loss drug Ozempic by allowing generics onto the market.

Consumer advocacy group Public Citizen on Monday urged the Department of Health and Human Services to allow “any and all patents necessary” to be used by generic manufacturers to make lower-cost versions of Ozempic and Wegovy. Such generics can supply federal programs such as Medicare and “facilitate competition and make the treatments more affordable and accessible,” Public Citizen said in a letter to HHS Secretary Xavier Becerra.

Drugmaker Novo Nordisk sells Wegovy and Ozempic. The “outrageous pricing” ...